Skip to main content
. 2021 Sep 29;15(6):99. doi: 10.3892/br.2021.1475

Table IV.

Primary pathway targets.

Pathway in Primary targets
Cancer ABL1, AKT1, AR, CDK2, CREBBP, EGFR, CTNNB1, EP300
Prostate cancer CDK2, CREBBP, EP300, AKT1, EGFR, MAPK1
Viral carcinogenesis CDK2, CREBBP, EP300, GRB2, JUN, MDM2, NFKBIA, MAPK1
Estrogen signaling AKT1, EGFR, ESR1, GRB2, HSPA1A, HSPA1B, HSPA8, HSP90AA1
Thyroid hormone signaling ACTB, AKT1, CREBBP, CTNNB1, EP300, ESR1, HDAC1
Epstein-Barr virus infection AKT1, CDK2, CREBBP, EP300, HDAC1, HSPA1A, HSPA1B, HSPA8
PI3K-Akt signaling AKT1, BRCA1, CDK2, EGFR, FN1, HSP90AA1, HSP90AB1
MAPK signaling AKT1, ARRB2, EGFR, FLNA, GRB2, HSPA1, AHSPA1B, HSPA8